Back to News
Market Impact: 0.25

Validea Detailed Fundamental Analysis

ELVNDAQ
Company FundamentalsAnalyst InsightsHealthcare & BiotechCapital Returns (Dividends / Buybacks)Market Technicals & FlowsInvestor Sentiment & Positioning
Validea Detailed Fundamental Analysis

Validea's Multi-Factor Investor model, based on Pim van Vliet's low-volatility strategy, assigns Elevance Health (ELV) an 81% rating, signaling 'some interest' due to its underlying fundamentals and valuation. ELV, a large-cap growth stock in the Insurance sector, notably passes the model's market capitalization and standard deviation (low volatility) criteria, aligning with the strategy's core tenet of seeking high returns from low-risk equities. This indicates ELV is flagged by a prominent quantitative low-volatility approach.

Analysis

Elevance Health (ELV) has been identified by Validea's Multi-Factor Investor model, which is based on Pim van Vliet's low-volatility strategy, receiving an 81% rating. This score suggests a moderate level of interest from the quantitative screen. The analysis highlights that ELV, a large-cap insurance stock, successfully passes the model's core criteria for market capitalization and low standard deviation, aligning it with the strategy's primary focus on conservative, low-risk equities. However, the stock's profile is diluted by neutral ratings on two other key factors: 'Twelve Minus One Momentum' and 'Net Payout Yield,' indicating that its recent price performance and shareholder return policies are not currently considered strengths by the model. Critically, despite the positive 81% score, ELV receives a 'FAIL' on the model's final rank, suggesting that the weakness in momentum and yield outweighs the benefits of its low-volatility characteristic, ultimately preventing a full endorsement from this specific strategy.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo